Legal Representation
Attorney
Christopher N. Bolinger
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 19, 2007 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Mar 17, 2007 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Aug 18, 2006 | CNRT | O | NON-FINAL ACTION MAILED |
| Aug 17, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 9, 2006 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Jan 6, 2006 | CNSL | F | LETTER OF SUSPENSION MAILED |
| Jan 5, 2006 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Jan 3, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 20, 2005 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, insomnia preparations and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005